Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Giovanni Dothel, Maria Raffaella Barbaro, Emanuel Raschi, Giovanni Barbara & Fabrizio De Ponti. (2018) Advancements in drug development for diarrhea-predominant irritable bowel syndrome. Expert Opinion on Investigational Drugs 27:3, pages 251-263.
Read now
Read now
Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now
Read now
Articles from other publishers (56)
Yuan-Ye Qiu, Jing Zhang, Fan-Yi Zeng & Yi Zhun Zhu. (2023) Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Pharmacological Research 192, pages 106786.
Crossref
Crossref
Alazne Moreno-Lanceta, Mireia Medrano-Bosch, Blanca Simón-Codina, Montserrat Barber-González, Wladimiro Jiménez & Pedro Melgar-Lesmes. (2023) PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer–Graphene Nanostars Reduces Liver Fibrosis and Inflammation. Pharmaceutics 15:5, pages 1452.
Crossref
Crossref
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Suhas Tambe, Sudeep CA, Ashok Kumar Pattnaik, Venkatesan Jayaprakash, Paolo Paoli, Antonio Lavecchia & Fulvio Loiodice. (2023) A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of Medicinal Chemistry 66:5, pages 3566-3587.
Crossref
Crossref
Enrico D’Aniello, Pietro Amodeo & Rosa Vitale. (2023) Marine Natural and Nature-Inspired Compounds Targeting Peroxisome Proliferator Activated Receptors (PPARs). Marine Drugs 21:2, pages 89.
Crossref
Crossref
Agnieszka Jaworowska & Aliza Murtaza. (2022) Seaweed Derived Lipids Are a Potential Anti-Inflammatory Agent: A Review. International Journal of Environmental Research and Public Health 20:1, pages 730.
Crossref
Crossref
Yusaku Miyamae. (2022) A Screening System for the Identification of Fragment Molecules toward the Creation of Nuclear Receptor Ligandsリガンド結合ポケットの特性を利用したフラグメント分子スクリーニングと核内受容体リガンドの創製. YAKUGAKU ZASSHI 142:12, pages 1345-1351.
Crossref
Crossref
Mengnan Liu, Xingru Long, Jie Xu, Mingtai Chen, Huayi Yang, Xin Guo, Junli Kang, Yue Ouyang, Gang Luo, Sijin Yang & Hua Zhou. (2022) Hypertensive heart disease and myocardial fibrosis: How traditional Chinese medicine can help addressing unmet therapeutical needs. Pharmacological Research 185, pages 106515.
Crossref
Crossref
Yiqi Li, Yeli Li, Nana Chen, Linying Feng, Jianmei Gao, Nan Zeng, Zhixu He & Qihai Gong. (2022) Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling Pathway. Antioxidants 11:9, pages 1705.
Crossref
Crossref
Sabina Sblano, Carmen Cerchia, Antonio Laghezza, Luca Piemontese, Leonardo Brunetti, Rosalba Leuci, Federica Gilardi, Aurelien Thomas, Massimo Genovese, Alice Santi, Paolo Tortorella, Paolo Paoli, Antonio Lavecchia & Fulvio Loiodice. (2022) A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivity. European Journal of Medicinal Chemistry 235, pages 114240.
Crossref
Crossref
Gargi Dixit & Arati Prabhu. (2022) The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics. Experimental and Molecular Pathology 124, pages 104723.
Crossref
Crossref
Rosalba Leuci, Leonardo Brunetti, Antonio Laghezza, Luca Piemontese, Antonio Carrieri, Leonardo Pisani, Paolo Tortorella, Marco Catto & Fulvio Loiodice. (2022) A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE). Molecules 27:3, pages 958.
Crossref
Crossref
Mingyu Hu, Ji Li, Philip N. Baker & Chao Tong. (2021) Revisiting preeclampsia: a metabolic disorder of the placenta. The FEBS Journal 289:2, pages 336-354.
Crossref
Crossref
T. Ollewagen, K. H. Myburgh, M. van de Vyver & C. Smith. (2021) Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche. Journal of Biomedical Science 28:1.
Crossref
Crossref
Yusaku Miyamae. (2021) Insights into Dynamic Mechanism of Ligand Binding to Peroxisome Proliferator-Activated Receptor γ toward Potential Pharmacological Applications. Biological and Pharmaceutical Bulletin 44:9, pages 1185-1195.
Crossref
Crossref
Zacharias Pandelides, Neelakanteswar Aluru, Cammi Thornton, Haley E Watts & Kristine L Willett. (2021) Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol. Toxicological Sciences.
Crossref
Crossref
Yan Tan, Mina Wang, Ke Yang, Tiange Chi, Zehuan Liao & Peng Wei. (2021) PPAR-α Modulators as Current and Potential Cancer Treatments. Frontiers in Oncology 11.
Crossref
Crossref
Jean-Charles Fruchart, Michel P. Hermans, Jamila Fruchart-Najib & Tatsuhiko Kodama. (2021) Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?. Current Atherosclerosis Reports 23:1.
Crossref
Crossref
Dutta D, Bhattacharya S, Surana V, Aggarwal S, Singla R, Khandelwal D & Sharma M. (2020) Response to the letter to the Editor submitted by Jaiswal A et al. (2020) regarding ‘Efficacy and safety of Saroglitazar in managing hypertriglyceridemia in type-2 diabetes: A meta-analysis’ (Dutta et al.). Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
Crossref
Crossref
Allegra Kaufman, Lubna Abuqayyas, William S. Denney, Erik J. Tillman & Tim Rolph. (2020) AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients. Cell Reports Medicine 1:4, pages 100057.
Crossref
Crossref
Marialuigia Fantacuzzi, Barbara De Filippis, Rosa Amoroso & Letizia Giampietro. (2019) PPAR Ligands Containing Stilbene Scaffold. Mini-Reviews in Medicinal Chemistry 19:19, pages 1599-1610.
Crossref
Crossref
Maria Grandoch, Ulrich Flögel, Sam Virtue, Julia K. Maier, Tomas Jelenik, Christina Kohlmorgen, Kathrin Feldmann, Yanina Ostendorf, Tamara R. Castañeda, Zhou Zhou, Yu Yamaguchi, Emmani B. M. Nascimento, Vivekananda G. Sunkari, Christine Goy, Martina Kinzig, Fritz Sörgel, Paul L. Bollyky, Patrick Schrauwen, Hadi Al-Hasani, Michael Roden, Susanne Keipert, Antonio Vidal-Puig, Martin Jastroch, Judith Haendeler & Jens W. Fischer. (2019) 4-Methylumbelliferone improves the thermogenic capacity of brown adipose tissue. Nature Metabolism 1:5, pages 546-559.
Crossref
Crossref
Benjamin Korman, Roberta Goncalves Marangoni, Gabriel Lord, Jerrold Olefsky, Warren Tourtellotte & John Varga. (2018) Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Sara Moses, Ulf Andersson & Martin Billger. 2018. Early Drug Development. Early Drug Development
499
526
.
Fan Hong, Pengfei Xu & Yonggong Zhai. (2018) The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development. International Journal of Molecular Sciences 19:8, pages 2189.
Crossref
Crossref
Reinhard Brunmeir & Feng Xu. (2018) Functional Regulation of PPARs through Post-Translational Modifications. International Journal of Molecular Sciences 19:6, pages 1738.
Crossref
Crossref
Filip Fratev, Thomas Steinbrecher & Svava Ósk Jónsdóttir. (2018) Prediction of Accurate Binding Modes Using Combination of Classical and Accelerated Molecular Dynamics and Free-Energy Perturbation Calculations: An Application to Toxicity Studies. ACS Omega 3:4, pages 4357-4371.
Crossref
Crossref
Margherita Botta, Matteo Audano, Amirhossein Sahebkar, Cesare Sirtori, Nico Mitro & Massimiliano Ruscica. (2018) PPAR Agonists and Metabolic Syndrome: An Established Role?. International Journal of Molecular Sciences 19:4, pages 1197.
Crossref
Crossref
Bharat Lagu, Arthur F. Kluge, Matthew M. Goddeeris, Effie Tozzo, Ross A. Fredenburg, Shekar Chellur, Ramesh S. Senaiar, Mahaboobi Jaleel, D. Ravi Krishna Babu, Nirbhay K. Tiwari, Taisuke Takahashi & Michael A. Patane. (2018) Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516. Bioorganic & Medicinal Chemistry Letters 28:3, pages 533-536.
Crossref
Crossref
Jean-Marc Cavaillon & Mervyn SingerMarleen M.J. van Greevenbroek, Casper G. Schalkwijk & Coen D.A. Stehouwer. 2017. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Inflammation - From Molecular and Cellular Mechanisms to the Clinic
1225
1254
.
Dmytro Kukhtar, Miquel Mulero, Raul Beltrán-Debón, Cristina Valls, Gerard Pujadas & Santiago Garcia-Vallve. 2017. Drug Selectivity. Drug Selectivity
397
432
.
Caroline Platt & Richard J. Coward. (2016) Peroxisome proliferator activating receptor-γ and the podocyte. Nephrology Dialysis Transplantation, pages gfw320.
Crossref
Crossref
Jason S. Rockel & Mohit Kapoor. (2016) Autophagy: controlling cell fate in rheumatic diseases. Nature Reviews Rheumatology 12:9, pages 517-531.
Crossref
Crossref
Gavin O'Mahony. 2016. Bioactive Carboxylic Compound Classes: Pharmaceuticals and Agrochemicals. Bioactive Carboxylic Compound Classes: Pharmaceuticals and Agrochemicals
39
56
.
Jacqueline J.T. Liaw & Philip V. Peplow. (2016) Effect of Electroacupuncture on Inflammation in the Obese Zucker Fatty Rat Model of Metabolic Syndrome. Journal of Acupuncture and Meridian Studies 9:2, pages 73-79.
Crossref
Crossref
Anthony J Apostoli, Jennifer M Roche, Mark M Schneider, Sandip K SenGupta, Michael A Di Lena, Rachel E Rubino, Nichole T Peterson & Christopher JB Nicol. (2015) Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression. Molecular Cancer 14:1.
Crossref
Crossref
Xiao-Rong Peng, Peter Gennemark, Gavin O’Mahony & Stefano Bartesaghi. (2015) Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity. Frontiers in Endocrinology 6.
Crossref
Crossref
Ming-Chang Chiang, Yi-Chuan Cheng, Christopher J. Nicol, Kuan-Hung Lin, Chia-Hui Yen, Shiang-Jiuun Chen & Rong-Nan Huang. (2015) Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells. Experimental Cell Research 338:2, pages 183-193.
Crossref
Crossref
Francesco Ferraù & Márta Korbonits. (2015) Metabolic comorbidities in Cushing's syndrome. European Journal of Endocrinology 173:4, pages M133-M157.
Crossref
Crossref
Santiago Garcia-Vallvé, Laura Guasch, Sarah Tomas-Hernández, Josep Maria del Bas, Vincent Ollendorff, Lluís Arola, Gerard Pujadas & Miquel Mulero. (2015) Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Ligand Choreography: Newcomers Take the Stage. Journal of Medicinal Chemistry 58:14, pages 5381-5394.
Crossref
Crossref
I. Briguglio, S. Piras, P. Corona, E. Gavini, M. Nieddu, G. Boatto & A. Carta. (2015) Benzotriazole: An overview on its versatile biological behavior. European Journal of Medicinal Chemistry 97, pages 612-648.
Crossref
Crossref
Kohei Kawata, Ken-ichi Morishita, Mariko Nakayama, Shoya Yamada, Toshiki Kobayashi, Yuki Furusawa, Sakae Arimoto-Kobayashi, Toshitaka Oohashi, Makoto Makishima, Hirotaka Naitou, Erika Ishitsubo, Hiroaki Tokiwa, Akihiro Tai & Hiroki Kakuta. (2014) RXR Partial Agonist Produced by Side Chain Repositioning of Alkoxy RXR Full Agonist Retains Antitype 2 Diabetes Activity without the Adverse Effects. Journal of Medicinal Chemistry 58:2, pages 912-926.
Crossref
Crossref
Mathieu C. Morissette, Pamela Shen, Danya Thayaparan & Martin R. Stämpfli. (2015) Impacts of peroxisome proliferator-activated receptor-γ activation on cigarette smoke-induced exacerbated response to bacteria. European Respiratory Journal 45:1, pages 191-200.
Crossref
Crossref
Jihan Youssef & Mostafa Badr. (2015) Peroxisome Proliferator-Activated Receptors Features, Functions, and Future. Nuclear Receptor Research 2.
Crossref
Crossref
Manoj Kumar Sadasivuni, Bobbili Madhusudhan Reddy, Jaideep Singh, Mammen O Anup, Venkategowda Sunil, Mudigere N Lakshmi, Sivakumaran Yogeshwari, Suni K Chacko, Talanki Lokesh Pooja, Anilkumar Dandu, Chandrashekaran Harish, Aralakuppe S Gopala, Shivakumar Pratibha, Baisani S Naveenkumar, Puttrevana M Pallavi, Mahesh Kumar Verma, Yoganand Moolemath, Baggavalli P Somesh, Marikunte V Venkataranganna & Madanahalli R Jagannath. (2014) CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models. Diabetology & Metabolic Syndrome 6:1.
Crossref
Crossref
Rongxue Wu, Hsiang-Chun Chang, Arineh Khechaduri, Kusum Chawla, Minh Tran, Xiaomeng Chai, Cory Wagg, Mohsen Ghanefar, Xinghang Jiang, Marina Bayeva, Frank Gonzalez, Gary Lopaschuk & Hossein Ardehali. (2014) Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy. Journal of Clinical Investigation 124:11, pages 4795-4806.
Crossref
Crossref
Matthew B. WrightMichele BortoliniMoh Tadayyon & Martin Bopst. (2014) Minireview: Challenges and Opportunities in Development of PPAR Agonists. Molecular Endocrinology 28:11, pages 1756-1768.
Crossref
Crossref
Elizabeth Buzney, Johanna Sheu, Catherine Buzney & Rachel V. Reynolds. (2014) Polycystic ovary syndrome: A review for dermatologists. Journal of the American Academy of Dermatology 71:5, pages 859.e1-859.e15.
Crossref
Crossref
Harry Preuss & Jeffrey Preuss. 2014. Metabolic Medicine and Surgery. Metabolic Medicine and Surgery
183
206
.
Kate A. Parham, Stuart M. Pitson & Claudine S. Bonder. (2014) Regulation of EPCs: The Gateway to Blood Vessel Formation. New Journal of Science 2014, pages 1-16.
Crossref
Crossref
Richard M. Turner, Chun S. Kwok, Chen Chen-Turner, Chinedu A. Maduakor, Sonal Singh & Yoon K. Loke. (2014) Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis. British Journal of Clinical Pharmacology 78:2, pages 258-273.
Crossref
Crossref
Jason Gien, Nancy TsengGregory Seedorf, Gates RoeSteven H. Abman. (2014) Peroxisome proliferator activated receptor-γ-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 306:3, pages L299-L308.
Crossref
Crossref
Daniele Piomelli & Oscar Sasso. (2014) Peripheral gating of pain signals by endogenous lipid mediators. Nature Neuroscience 17:2, pages 164-174.
Crossref
Crossref
Santiago Garcia-Vallve, Laura Guasch & Miquel Mulero. 2014. Foodinformatics. Foodinformatics
151
176
.
Pablo Quintero & Marco Arrese. (2013) Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism. Hepatology 58:6, pages 1881-1884.
Crossref
Crossref
Xiaohua Yi, Anjeza Pashaj, Mengna Xia & Régis Moreau. (2013) Reversal of obesity-induced hypertriglyceridemia by (R)-α-lipoic acid in ZDF (fa/fa) rats. Biochemical and Biophysical Research Communications 439:3, pages 390-395.
Crossref
Crossref
Alessandra Ammazzalorso, Barbara De Filippis, Letizia Giampietro & Rosa Amoroso. (2013) Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview. ChemMedChem, pages n/a-n/a.
Crossref
Crossref